AU647444B2 - Oxipurinol salt composition for oral administration for treating hyperurecemia - Google Patents

Oxipurinol salt composition for oral administration for treating hyperurecemia

Info

Publication number
AU647444B2
AU647444B2 AU69687/91A AU6968791A AU647444B2 AU 647444 B2 AU647444 B2 AU 647444B2 AU 69687/91 A AU69687/91 A AU 69687/91A AU 6968791 A AU6968791 A AU 6968791A AU 647444 B2 AU647444 B2 AU 647444B2
Authority
AU
Australia
Prior art keywords
hyperurecemia
oxipurinol
treating
oral administration
salt composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU69687/91A
Other versions
AU6968791A (en
Inventor
Veit Nitsche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biokinet Chemisches Laboratorium GmbH
Original Assignee
BIOKINET CHEM LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOKINET CHEM LAB filed Critical BIOKINET CHEM LAB
Publication of AU6968791A publication Critical patent/AU6968791A/en
Application granted granted Critical
Publication of AU647444B2 publication Critical patent/AU647444B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
AU69687/91A 1989-12-28 1990-12-20 Oxipurinol salt composition for oral administration for treating hyperurecemia Ceased AU647444B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT0295889A AT396427B (en) 1989-12-28 1989-12-28 PHARMACEUTICAL USE OF OXIPURINOL SALT
AT2958/89 1989-12-28
PCT/AT1990/000126 WO1991009600A1 (en) 1989-12-28 1990-12-20 Oxipurinol salt composition for oral administration for treating hyperurecemia

Publications (2)

Publication Number Publication Date
AU6968791A AU6968791A (en) 1991-07-24
AU647444B2 true AU647444B2 (en) 1994-03-24

Family

ID=3543074

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69687/91A Ceased AU647444B2 (en) 1989-12-28 1990-12-20 Oxipurinol salt composition for oral administration for treating hyperurecemia

Country Status (8)

Country Link
EP (1) EP0461218B1 (en)
AT (1) AT396427B (en)
AU (1) AU647444B2 (en)
DE (1) DE59003806D1 (en)
DK (1) DK0461218T3 (en)
ES (1) ES2062752T3 (en)
RU (1) RU2016571C1 (en)
WO (1) WO1991009600A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006083687A1 (en) * 2005-01-28 2006-08-10 Cardiome Pharma Corp. Crystal salt of xanthine oxidase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624205A (en) * 1967-04-25 1971-11-30 Burroughs Wellcome Co Treatment of hyperuricemia in humans
EP0237348B1 (en) * 1986-03-13 1990-09-05 The Wellcome Foundation Limited Cell protection

Also Published As

Publication number Publication date
EP0461218B1 (en) 1993-12-08
WO1991009600A1 (en) 1991-07-11
DK0461218T3 (en) 1994-04-18
ES2062752T3 (en) 1994-12-16
RU2016571C1 (en) 1994-07-30
AU6968791A (en) 1991-07-24
ATA295889A (en) 1993-01-15
AT396427B (en) 1993-09-27
DE59003806D1 (en) 1994-01-20
EP0461218A1 (en) 1991-12-18

Similar Documents

Publication Publication Date Title
AU7061687A (en) Pharmaceutical composition for treating periodontal diseases
AU618730B2 (en) Salt-containing pharmaceutical compositions
AU634746B2 (en) Effervescent composition for oral rehydration
AU5970290A (en) Dental composition
AU5157590A (en) Pharmaceutical compositions for oral administration
IL95158A0 (en) Pharmaceutical composition for oral administration containing n-acetyl-cysteine
AU3746489A (en) Glycosaminoglycan salts, processes for the preparation thereof and pharmaceutical compositions containing them
GB8825892D0 (en) Pharmaceutical composition
AU2345988A (en) Pharmaceutical composition for piperidinoalkanol-decongestant combination
AU2346088A (en) Pharmaceutical composition for piperidinoalkanol derivatives
AU4452789A (en) Antibacterial oral composition
GB2232891B (en) Pharmaceutical composition
AU4939690A (en) Anesthetic oral compositions
ZA893422B (en) Pharmaceutical composition
AU647444B2 (en) Oxipurinol salt composition for oral administration for treating hyperurecemia
AU3723589A (en) Therapeutic composition
AU3510489A (en) Pharmaceutical composition for treating tumor
AU2876889A (en) Pharmaceutical composition for 4-aroylimidazol-2-ones
AU4102789A (en) Treatment compositions
AU3298589A (en) New pharmaceutical composition
AU4093789A (en) Transermal therapeutic composition
AU1228988A (en) Cephalosporin compounds or their salts, process for their preparation, and pharmaceutical compositions
AU7819887A (en) Pharmaceutical composition
GB8811718D0 (en) Pharmaceutical compositions & treatment
GB8809329D0 (en) Pharmaceutical compositions & treatment